Lucid Diagnostics Files 2024 10-K
Ticker: LUCD · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1799011
Sentiment: neutral
Topics: 10-K, financials, medical-devices
Related Tickers: LUCD
TL;DR
Lucid Diagnostics dropped its 2024 10-K, check financials for LUCD.
AI Summary
Lucid Diagnostics Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 24, 2025. The company, based in New York, operates in the surgical and medical instruments sector. The filing covers financial data and business operations for the period, including details on preferred and common stock, additional paid-in capital, and retained earnings for the years 2022, 2023, and 2024.
Why It Matters
This 10-K filing provides a comprehensive overview of Lucid Diagnostics' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a medical device company, Lucid Diagnostics faces inherent risks related to regulatory approvals, market adoption, and competition, which are detailed in their 10-K filings.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-24 — Filing Date (The date the 10-K was submitted to the SEC.)
- 2024 — Reporting Period (The fiscal year for which financial information is reported.)
- 2023 — Previous Fiscal Year (Comparative financial data from the prior year.)
- 2022 — Prior Fiscal Year (Comparative financial data from two years prior.)
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-24 (date) — Filing date
- 360 Madison Avenue, New York, NY 10017 (address) — Company business and mail address
- LUCD (ticker) — Company ticker symbol
FAQ
What were Lucid Diagnostics' total revenues for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024. It primarily details the filing information and financial statement components.
What is the company's primary business as described in the 10-K?
Lucid Diagnostics Inc. is classified under the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]' Standard Industrial Classification, indicating its business is in the medical device sector.
When was the 10-K filing submitted to the SEC?
The 10-K filing for Lucid Diagnostics Inc. was submitted to the SEC on March 24, 2025.
What are the key financial statement components mentioned for the fiscal years 2022-2024?
The filing mentions components such as Series B Preferred Stock, Series B One Preferred Stock, Series A Preferred Stock, Series A One Preferred Stock, Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings for the fiscal years ending 2022, 2023, and 2024.
Where is Lucid Diagnostics Inc. headquartered?
Lucid Diagnostics Inc.'s business and mail address is listed as 360 Madison Avenue, 25th Floor, New York, NY 10017.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding Lucid Diagnostics Inc. (LUCD).